India’s Union health budget 2012–13

The Indian healthcare industry is witnessing growth at a rapid
pace, with its growth rate being far higher than the overall growth
rate of the economy. The allocation to health in the Union budget,
2012–13 was hence of prime concern to all stakeholders. In this
year’s budget, the Finance Minister increased the outlay for health
from the previous year’s fiscal allocation of `304 560 million to
`348 888 million, a significant rise of 13.24%. ‘This is just a
cosmetic change. The rise in absolute number only takes care of
price rise and inflation….

Read More about this article by Dr Soumyadeep B’s at : National Medicaj Journal of India 

Data used to justify Indian HPV vaccination trial questioned

A trial of human papillomavirus (HPV) vaccines in India, halted by the Indian Government in 2010, ran into fresh controversy with the publication of a study suggesting that the trial should not have been started in the first place.
The HPV vaccine trial of more than 23 000 girls from Gujarat and Andhra Pradesh, run by the Program for Appropriate Technology in Health (PATH), an international charity, was suspended by the Indian Government after reports of deaths of four girls in the trial and subs …
Read the full article by Dr. Soumyadeep B at : The Lancet Oncology